GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 56 filers reported holding GT BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,962 | -22.7% | 95,239 | 0.0% | 0.00% | – |
| Q2 2023 | $29,714 | -43.3% | 95,239 | 0.0% | 0.00% | – |
| Q1 2023 | $52,382 | -37.9% | 95,239 | 0.0% | 0.00% | – |
| Q4 2022 | $84,353 | -49.5% | 95,239 | 0.0% | 0.00% | – |
| Q3 2022 | $167,000 | -43.2% | 95,239 | -3.5% | 0.00% | – |
| Q2 2022 | $294,000 | -28.1% | 98,664 | -30.5% | 0.00% | – |
| Q1 2022 | $409,000 | -7.3% | 142,048 | -2.1% | 0.00% | – |
| Q4 2021 | $441,000 | -52.3% | 145,123 | +5.8% | 0.00% | – |
| Q3 2021 | $925,000 | +1.6% | 137,156 | +133.6% | 0.00% | – |
| Q2 2021 | $910,000 | – | 58,711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baskin Financial Services Inc. | 151,354 | $36 | 0.00% |
| Moss Adams Wealth Advisors LLC | 20,000 | $4,822 | 0.00% |
| UBS Group AG | 8,750 | $2,109 | 0.00% |
| Compagnie Lombard Odier SCmA | 50,000 | $12,055 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,270 | $305 | 0.00% |
| FMR LLC | 150 | $36 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 508 | $122 | 0.00% |
| WELLS FARGO & COMPANY/MN | 300,697 | $72,498 | 0.00% |
| NORTHERN TRUST CORP | 32,347 | $7,799 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |